Gabelli Healthcare & Wellness Rx Trust GRX
We take great care to ensure that the data presented and summarized in this overview for Gabelli Healthcare & WellnessRx Trust is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GRX
View all-
Saba Capital Management, L.P. New York, NY2.05MShares$19.3 Million0.56% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN834KShares$7.85 Million0.15% of portfolio
-
Wells Fargo & Company San Francisco, CA370KShares$3.48 Million0.0% of portfolio
-
Mario Gabelli Gamco Investors, Inc. Et Al | Rye, Ny312KShares$2.94 Million0.03% of portfolio
-
Lpl Financial LLC Fort Mill, SC286KShares$2.69 Million0.0% of portfolio
-
Blue Bell Private Wealth Management, LLC278KShares$2.61 Million0.4% of portfolio
-
Morgan Stanley New York, NY194KShares$1.83 Million0.0% of portfolio
-
Bennicas & Associates, Inc.165KShares$1.55 Million1.08% of portfolio
-
Aviance Capital Partners, LLC Naples, FL164KShares$1.54 Million0.19% of portfolio
-
Sanctuary Advisors, LLC Indianapolis, IN150KShares$1.41 Million0.01% of portfolio
Latest Institutional Activity in GRX
Top Purchases
Top Sells
About GRX
The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.
Insider Transactions at GRX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2025
|
Mario J Gabelli Director |
BUY
Open market or private purchase
|
Direct |
2,500
+1.03%
|
$22,500
$9.69 P/Share
|
|
Nov 25
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,451
+0.68%
|
$130,059
$9.62 P/Share
|
|
Oct 30
2025
|
Mario J Gabelli Director |
BUY
Open market or private purchase
|
Indirect |
1,800,000
+47.37%
|
$18,000,000
$10.18 P/Share
|
|
Oct 23
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,808
+0.99%
|
$187,272
$9.28 P/Share
|
|
Oct 22
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,053
+0.05%
|
$9,477
$9.31 P/Share
|
|
Oct 21
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,122
+0.3%
|
$55,098
$9.29 P/Share
|
|
Oct 17
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,816
+0.28%
|
$52,344
$9.2 P/Share
|
|
Oct 16
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,520
+0.17%
|
$31,680
$9.18 P/Share
|
|
Oct 14
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
1,000
-31.4%
|
$9,000
$9.12 P/Share
|
|
Oct 13
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
1,000
-23.89%
|
$9,000
$9.15 P/Share
|
|
Oct 09
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
1,000
-19.29%
|
$9,000
$9.27 P/Share
|
|
Oct 08
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
1,000
-16.17%
|
$9,000
$9.26 P/Share
|
|
Sep 12
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,732
+0.38%
|
$69,588
$9.43 P/Share
|
|
Sep 11
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,147
+0.3%
|
$55,323
$9.43 P/Share
|
|
Sep 05
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
800
-11.45%
|
$7,200
$9.5 P/Share
|
|
Sep 04
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
200
-2.78%
|
$1,800
$9.5 P/Share
|
|
Aug 25
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,330
+0.55%
|
$101,970
$9.48 P/Share
|
|
Aug 21
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
19,101
+0.93%
|
$171,909
$9.43 P/Share
|
|
Aug 13
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
2,000
-21.77%
|
$18,000
$9.2 P/Share
|
|
Aug 06
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
2,000
-17.88%
|
$18,000
$9.12 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 2.03M shares |
|---|
| Other acquisition or disposition | 840K shares |
|---|---|
| Open market or private sale | 10.1K shares |